drugset / Trial / NCT03420638

EXPAREL Post-tonsillectomy Clinical Trial

NCT03420638 ↗

Phase 4 Unknown 38 enrolled Paul Hoff St. Joseph Mercy Ann Arbor · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Tonsillectomy is one of the most commonly performed surgical procedures in the United States. The primary indications for tonsillectomy in the adult population include recurrent pharyngitis, chronic tonsillitis, and obstructive pathology. Tonsillectomy is often associated with severe postoperative pain, which can result in prolonged poor oral intake, dehydration, and the need for high dose narcotics. In severely dehydrated patients, epithelial shedding and necrosis of soft tissues at the surgical site can lead to postoperative complications such as bleeding, delayed healing, and severe pain. The goal for this study is to explore the use of a long acting local anesthetic bupivacaine liposome injectable suspension (Exparel) to manage pain experienced by adult patients after tonsillectomy

Timeline

Start
2018-02-15
Primary completion
2021-12-31
Completion
2021-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Bupivacaine Other / unclassified 13.3 mg/ml Intramuscular
Background Bupivacaine Other / unclassified 2.5 mg/ml Intramuscular
Background Epinephrine Other / unclassified 5 ug/ml Intramuscular

Indications